LP
LGL Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $592K | Sell |
6,941
-4,990
| -42% | -$426K | 0.26% | 32 |
|
|
2025
Q1 | $968K | Sell |
11,931
-6,418
| -35% | -$521K | 0.47% | 23 |
|
|
2024
Q4 | $1.65M | Sell |
18,349
-1,905
| -9% | -$172K | 0.24% | 34 |
|
|
2024
Q3 | $2M | Buy |
20,254
+2
| +0% | +$198 | 0.28% | 29 |
|
|
2024
Q2 | $1.88M | Sell |
20,252
-2,221
| -10% | -$206K | 0.27% | 30 |
|
|
2024
Q1 | $2.13M | Sell |
22,473
-340
| -1% | -$32.3K | 0.36% | 29 |
|
|
2023
Q4 | $2.04M | Sell |
22,813
-138
| -0.6% | -$12.3K | 0.28% | 30 |
|
|
2023
Q3 | $1.68M | Sell |
22,951
-763
| -3% | -$55.7K | 0.29% | 29 |
|
|
2023
Q2 | $1.97M | Sell |
23,714
-650
| -3% | -$54.1K | 0.34% | 25 |
|
|
2023
Q1 | $1.86M | Sell |
24,364
-3,790
| -13% | -$289K | 0.32% | 25 |
|
|
2022
Q4 | $2.34M | Sell |
28,154
-1,149
| -4% | -$95.4K | 0.42% | 23 |
|
|
2022
Q3 | $2.32M | Buy |
29,303
+13,568
| +86% | +$1.08M | 0.48% | 22 |
|
|
2022
Q2 | $1.17M | Buy |
15,735
+12,210
| +346% | +$907K | 0.19% | 27 |
|
|
2022
Q1 | $317K | Buy |
+3,525
| New | +$317K | 0.04% | 74 |
|